Cellspinsoft Inc. v. LifeScan Inc.

Cellspinsoft Inc. initiated a patent infringement lawsuit against LifeScan Inc. in the Eastern District of Texas on April 29, 2024. The plaintiff, Cellspinsoft Inc., appears to be a non-practicing entity (NPE) or patent assertion entity (PAE), known for an aggressive litigation strategy involving numerous lawsuits against various technology companies over data transfer patents. Defendant LifeScan Inc. is an operating company and a global leader in diabetes management, specializing in blood glucose monitoring systems and digital health solutions under its OneTouch brand.

The core of the dispute revolves around U.S. Patent No. 8,904,030. This patent is broadly directed to a system and method for uploading data to a remote server from a device that lacks direct network connectivity. The patented technology involves transferring data from a capturing device to a mobile device via Bluetooth, and subsequently, the mobile device uploads this data. The system is designed such that the capturing device can notify the mobile device when new data is available for upload. While specific accused products are not explicitly detailed in publicly available initial filings, LifeScan's product portfolio includes various OneTouch blood glucose meters and integrated digital health platforms, such as the OneTouch Reveal mobile app, which often feature Bluetooth connectivity for syncing data. It is highly probable that these data-enabled blood glucose monitoring systems and associated applications are the accused infringing technology.

The case is proceeding in the U.S. District Court for the Eastern District of Texas, case number 2:24-cv-00286. While the specific division and assigned judge are not immediately detailed in the initial filing data, cases with this numbering convention (2:XX-cv) are typically handled in the Marshall Division of the Eastern District of Texas, a venue widely recognized for its high volume of patent litigation and its patentee-friendly reputation. This case is notable due to Cellspinsoft's established pattern as an NPE with an aggressive enforcement history, including prior attempts to seek Supreme Court review on issues of judicial recusal and eligibility under 35 U.S.C. § 101 in related patent cases. Furthermore, the litigation has a direct linkage to inter partes review (IPR) proceedings at the Patent Trial and Appeal Board (PTAB), with LifeScan Inc. (among others) challenging related Cellspinsoft patents, specifically IPR2025-00103 concerning U.S. Patent No. 9,900,766, which explicitly references the ongoing district court case. This parallel PTAB action highlights a common defense strategy against NPE assertions and underscores the broader challenges to Cellspinsoft's patent portfolio.

Cellspinsoft Inc. v. LifeScan Inc., filed in the Texas Eastern District Court (Case No. 2:24-cv-00286), involves allegations of infringement of U.S. Patent 8,904,030. The case was filed on April 29, 2024, and is currently open.

Here are the key legal developments to date:

Filing & Initial Pleadings:

• April 29, 2024: Cellspinsoft Inc. filed a patent infringement lawsuit against LifeScan Inc. in the Eastern District of Texas, asserting U.S. Patent No. 8,904,030.

Parallel PTAB Proceedings & Related Challenges:

• July 25, 2024: The Central Reexamination Unit (CRU) granted a request for ex parte reexamination of U.S. Patent 8,904,030, the patent asserted in this litigation. Unified Patents initiated this reexamination, finding substantial new questions of patentability regarding the challenged claims. The '030 patent generally relates to uploading data to a remote server from a device lacking direct network connectivity, where data is transferred via Bluetooth to a mobile device for upload.
• September 30, 2024: An Inter Partes Review (IPR) was instituted (IPR2024-00769) by TikTok Inc. challenging U.S. Patent No. 9,900,766, another patent owned by Cellspinsoft Inc.
• October 2024 (approximate, within one month of institution): LifeScan Inc., along with Senseonics Holdings, Inc. and Ascensia Diabetes Care Holdings AG, filed a motion to join the IPR challenging U.S. Patent No. 9,900,766 (IPR2025-00103). The motion for joinder was submitted concurrently with LifeScan's own IPR petition for the '766 patent. The petitioners in this IPR motion are also defendants in district court litigations initiated by Cellspinsoft. Specifically, LifeScan Inc. is a defendant in the Eastern District of Texas case 2:24-cv-00286, where the Patent Owner (Cellspinsoft) has accused it of infringing the '766 patent.

Current Posture:
The district court case (2:24-cv-00286) remains open as of the current date. Given the filing date in April 2024, the litigation is still in its relatively early stages, likely proceeding through initial pleadings and discovery, with pre-trial motions and claim construction hearings yet to be publicly reported or scheduled. The ongoing ex parte reexamination of the asserted patent (8,904,030) could potentially lead to a stay of the district court proceedings or influence the scope of the claims. The related IPR for U.S. Patent 9,900,766, while not directly on the patent listed in the prompt for this specific case, indicates parallel legal challenges against Cellspinsoft's portfolio involving LifeScan.

I am unable to definitively identify the counsel of record representing Cellspinsoft Inc. in this specific patent infringement case (2:24-cv-00286) based on the current search results. Direct PACER access or a more specific legal news source for this particular case is needed to confirm the attorneys who have entered an appearance for the plaintiff.

While searches did reveal information about attorneys named Timothy P. Maloney and Jonathan W. Yarbrough with patent litigation experience, none of the provided snippets explicitly link them to Cellspinsoft Inc. as counsel in Cellspinsoft Inc. v. LifeScan Inc., case number 2:24-cv-00286.

However, general information on potentially relevant attorneys found through web searches includes:

• Timothy P. Maloney

  • Role: Experienced trial lawyer with a focus on intellectual property enforcement and defense, particularly patent litigation.
  • Firm: Nixon Peabody LLP, Chicago office.
  • Relevant experience: Has extensive first-chair trial experience, handles disputes before the US Court of Appeals for the Federal Circuit, and has a strong track record in inter partes review (IPR) proceedings. He was recognized as a top-performing attorney nationwide representing patent owners in IPR proceedings in 2017. He has more than 30 years of experience in IP and technology-related commercial litigation, including jury trials and Federal Circuit appeals.

• Jonathan W. Yarbrough

  • Role: Partner (at a general practice firm in the past, or currently at Constangy, Brooks, Smith & Prophete, LLP, though his listed practice areas do not specifically mention patent litigation).
  • Firm: Constangy, Brooks, Smith & Prophete, LLP, Asheville, NC office.
  • Relevant experience: While Martindale.com reviews indicate experience in litigation, employment law, and civil practice, there is no explicit mention of patent litigation in the provided snippets for this specific Jonathan W. Yarbrough. There are other attorneys named Yarbrough with patent law experience (e.g., William C. "Trey" Yarbrough with Kearney, McWilliams & Davis, PLLC and Robert J. Yarbrough specializing in patent law), but without case-specific docket information, it is not possible to confirm if any of these individuals are counsel of record for Cellspinsoft Inc. in this case.

As filings are not explicitly stated to be sealed, the lack of definitive information is due to the inability to directly access specific counsel appearances for this particular case through the conducted web searches.

In the patent infringement case Cellspinsoft Inc. v. LifeScan Inc., case number 2:24-cv-00286, the following counsel represents the defendant, LifeScan Inc.:

• Name: Ziyong "Sean" Li
  • Role: Counsel (the specific role of "lead counsel" vs. "of counsel" vs. "local counsel" is not explicitly stated in the appearance notice, but his firm profile indicates he serves as partner and lead counsel in various matters).
  • Firm: Benesch, Friedlander, Coplan & Aronoff LLP (Benesch Law)
  • Office Location: San Francisco, CA
  • Relevant Patent Litigation Experience: Sean Li is a partner in Benesch's Intellectual Property/3iP Practice Group and focuses on technology and intellectual property litigation, including patent, copyright, trademark, and trade secret disputes. He has experience across a wide range of technologies such as telecommunication standards, artificial intelligence, and microprocessor architecture designs. He is a registered patent attorney and has served as lead counsel in multiple Inter Partes Review (IPR) proceedings. His experience also includes representing clients in federal and state courts, the USPTO, and the ITC, and he has represented ASUSTek Computer in a federal bench trial involving semiconductor design in the Eastern District of Texas.